When it decreases, you don't just hurt lessyou have more energy, better sleep, and improved quality of life
Hruby and Mac Hadley (University of Arizona, USA) in 19871989 Original development program Competitive Technologies Palatin Technologies , later spun off into PT-141 (bremelanotide) Target: non-selective agonist of MC1R, MC3R, MC4R, MC5R (more potent than -MSH, longer half-life) Standard experimental dose in human tanning studies: 0.025 mg/kg subcutaneously (Dorr 1996) In Dorr 1996 (n=10): increase in skin melanin density measured by colorimetry by ~25 % after a 10-day course Main adverse effects in the preclinical literature: nausea, flushing, hyperpigmentation (including atypical nevi), priapism Approximately 100+ publications in PubMed
All injections should be performed only after instruction from a qualified healthcare professional , who will demonstrate the correct technique and safety steps for home use
Most users report peak visible change between months 3 and 6
DO NOT TUMBLE DRY